Skip to main content

Table 3 Predicted 1-year risk of ischemic stroke and bleeding based on Cox regression analysis

From: Comparison of antiplatelet regimens in secondary stroke prevention: a nationwide cohort study

  Risk of ischemic stroke Risk of bleeding
  3 months after stroke 6 months after stroke 12 months after stroke 3 months after stroke 6 months after stroke 12 months after stroke
Acetylsalicylic acid 3.6 [3.2; 4.0] 6.9 [6.3;7.7] 11.1 [10.2; 12.2] 1.2 [0.9; 1.4] 2.0 [1.6; 2.4] 3.4 [2.8; 3.9]
Acetylsalicylic acid and dipyridamole 2.4 [2.2; 2.7] 4.7 [4.4; 5.2] 7.7 [7.3; 8.3] 0.8 [0.7; 0.9] 1.4 [1.2; 1.6] 2.4 [2.1; 2.7]
Clopidogrel 2.5 [2.2; 2.9] 4.9 [4.3; 5.4] 8.0 [6.9; 8.7] 0.8 [0.6; 1.0] 1.4 [1.0; 1.7] 2.4 [1.9; 2.9]
  1. The model was adjusted for sex, age, year, prior myocardial infarction, hypertension, diabetes, peripheral artery disease, heart failure, chronic obstructive lung disease, and cancer